Your browser doesn't support javascript.
loading
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients.
Clark, Bradley C; Georgekutty, Justin; Berul, Charles I.
Affiliation
  • Clark BC; Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC. Electronic address: brclark@childrensnational.org.
  • Georgekutty J; Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
  • Berul CI; Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
J Pediatr ; 167(3): 757-61.e1, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26165442
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Designer Drugs / Myocardial Ischemia Limits: Adolescent / Humans / Male Language: En Journal: J Pediatr Year: 2015 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Designer Drugs / Myocardial Ischemia Limits: Adolescent / Humans / Male Language: En Journal: J Pediatr Year: 2015 Document type: Article Country of publication: United States